You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 65 No. 2, February 1952 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinical Notes
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

PROMACETIN® THERAPY OF DERMATITIS HERPETIFORMIS

LEON GOLDMAN, M.D.

AMA Arch Derm Syphilol. 1952;65(2):233.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Sulfoxone sodium (diasone®) has been used by Cornbleet1 since 1944 in the treatment of dermatitis herpetiformis. He has indicated that he has obtained good results. A much less toxic sulfone, also used in the treatment of leprosy, has been under study in the Department of Dermatology at the University of Cincinnati College of Medicine since 1949. This preparation is an acetosulfone (promacetin®) (sodium 4,4'-diaminodiphenylsulfone-2-acetylsulfonamide) for the treatment of sarcoidosis. The toxic reactions seen during this period of study have included only occasional nausea, one probable drug-allergy reaction of pharyngitis, and one drug fever. No serious blood or renal disturbances have been seen, even on prolonged courses. It appears, then, that promacetin® may be used when treatment must be continued for some time.

After Cornbleet's report, promacetin® was used in the treatment of nine patients with dermatitis herpetiformis with an average initial dose each . . . [Full Text PDF of this Article]


Author Affiliations

CINCINNATI

From the Department of Dermatology and Syphilology, University of Cincinnati College of Medicine.


Footnotes

Promacetin® was obtained from Eugene H. Payne, M.D., Parke, Davis & Company, Detroit.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1952 American Medical Association. All Rights Reserved.